CCR-3 receptor antagonists (I)

Details CCR-3 receptor antagonists (I) CCR-3 receptor antagonists (I)

2006-03-28

2006-03-28

O'Sullivan, Peter (Department: 1621)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S253010, C514S254100, C514S255030, C514S326000, C514S331000, C544S372000, C544S374000, C544S392000, C544S398000, C544S399000, C544S405000, C546S208000, C546S212000, C546S214000, C546S224000, C546S232000, C546S234000

Reexamination Certificate

active

07019007

ABSTRACT:
The invention provides compounds of Formula (I):wherein: R1–R4, A, D, and L have any of the values defined in the specification that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use, and methods and intermediates useful for preparing them.

REFERENCES:
patent: 5147876 (1992-09-01), Mizuchi et al.
patent: 5885999 (1999-03-01), Elliott et al.
patent: 6331541 (2001-12-01), Ko et al.
patent: 1 029 851 (2000-08-01), None
patent: 953 005 (1964-03-01), None
patent: 2 309 458 (1997-07-01), None
patent: WO 90/00548 (1990-01-01), None
patent: WO 97/23216 (1997-07-01), None
patent: WO 00/35449 (2000-06-01), None
patent: WO 00/35451 (2000-06-01), None
patent: WO 00/35452 (2000-06-01), None
patent: WO 00/35453 (2000-06-01), None
patent: WO 00/35454 (2000-06-01), None
patent: WO 01/07427 (2001-02-01), None
patent: 187838 (2001-11-01), None
U.S. Appl. No. 10/307,159, filed Nov. 29, 2002.
U.S. Appl. No. 10/307,130, filed Nov. 29, 2002.
PubMed Abstract 14733956, also cited as Biochem.Biophys. Res. Commn. 314/2,646-53(2004).
PubMed Abstract 12067561, also cited as Bioorg.Med.Chem.Lett., 12/13, 1785-9(2002).
PubMed Abstract 11964751, also cited as Curr. Opin. Alllergy. Clin. Immunol.2/1,53-9(2002).
PubMed Abstract 11773013, also cited as Invest. Ophthalmol. Vis. Sci. 43/1,58-62(2002).
PubMed Abstract 11680261, also cited as Am. J. Manag. Care 7/15,459-68(2001).
PubMed Abstract 11686879, also cited as Respir. res. 2/3,150-6(2001).
PubMed Abstract 11424898, also cited as Expert Opin Investig. Drugs. 10/3,547-60(2001).
Elliott et al., Chemical Abstracts, vol. 128:13439,1997.

Affiliated with

Also associated with

Rating

CCR-3 receptor antagonists (I) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CCR-3 receptor antagonists (I), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CCR-3 receptor antagonists (I) will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3547335